Tryptophan-Containing Non-Cationizable Opioid Peptides - a new chemotype with unusual structure and in vivo activity.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Future Medicinal Chemistry

• Publication date

  2017-11-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.4155/fmc-2017-0104PMID 29130348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endomorphin-1 analogs containing α-methyl-β-amino acids exhibit potent analgesic activity after peripheral administration.

  2017cited by this paper
• Redoubling the ring size of an endomorphin‐2 analog transforms a centrally acting mu‐opioid receptor agonist into a pure peripheral analgesic

  2016cited by this paper
• Versatile Picklocks To Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe-d-Pro-Phe-Trp] (CJ-15,208).

  2016cited by this paper
• Structure-based discovery of opioid analgesics with reduced side effects

  2016cited by this paper
• Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.

  2016cited by this paper
• Strategies to Improve Bioavailability and In Vivo Efficacy of the Endogenous Opioid Peptides Endomorphin-1 and Endomorphin-2.

  2015cited by this paper
• Structural insights into μ-opioid receptor activation

  2015cited by this paper
• Alanine analogues of [D‐Trp]CJ‐15,208: novel opioid activity profiles and prevention of drug‐ and stress‐induced reinstatement of cocaine‐seeking behaviour

  2014cited by this paper
• Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-D-alanine.

  2014cited by this paper
• Cyclic endomorphin analogs in targeting opioid receptors to achieve pain relief.

  2014cited by this paper
• Synthesis of tripeptides containing D-Trp substituted at the indole ring, assessment of opioid receptor binding and in vivo central antinociception.

  2014cited by this paper
• Easy preparation of dehydroalanine building blocks equipped with oxazolidin-2-one chiral auxiliaries, and applications to the stereoselective synthesis of substituted tryptophans

  2014cited by this paper
• The first one-pot synthesis of L-7-iodotryptophan from 7-iodoindole and serine, and an improved synthesis of other L-7-halotryptophans.

  2014cited by this paper
• The macrocyclic tetrapeptide [D‐Trp]CJ‐15,208 produces short‐acting κ opioid receptor antagonism in the CNS after oral administration

  2013cited by this paper
• Design, synthesis, and pharmacological characterization of novel endomorphin-1 analogues as extremely potent μ-opioid agonists.

  2013cited by this paper
• The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.

  2013cited by this paper
• Biomedical Importance of Indoles

  2013cited by this paper
• Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions

  2013cited by this paper
• In-peptide synthesis of di-oxazolidinone and dehydroamino acid-oxazolidinone motifs as β-turn inducers.

  2013cited by this paper
• Demystifying brain penetration in central nervous system drug discovery. Miniperspective.

  2013cited by this paper
• Hybrid peptides endomorphin-2/DAMGO: design, synthesis and biological evaluation.

  2013cited by this paper
• Enantioselective synthesis of tryptophan derivatives by a tandem Friedel-Crafts conjugate addition/asymmetric protonation reaction.

  2012cited by this paper
• Synthesis and biological evaluation of an orally active glycosylated endomorphin-1.

  2012cited by this paper
• Opioid Peptides: Potential for Drug Development.

  2012cited by this paper
• Structure of the δ-opioid receptor bound to naltrindole

  2012cited by this paper
• Structure of the human kappa opioid receptor in complex with JDTic

  2012cited by this paper
• Novel opioid cyclic tetrapeptides: Trp isomers of CJ‐15,208 exhibit distinct opioid receptor agonism and short‐acting κ opioid receptor antagonism

  2012cited by this paper
• The effect of Pro(2) modifications on the structural and pharmacological properties of endomorphin-2.

  2012cited by this paper
• Impact of lipophilic efficiency on compound quality.

  2012cited by this paper
• Lipo-Endomorphin-1 Derivatives with Systemic Activity against Neuropathic Pain without Producing Constipation

  2012cited by this paper
• Opioid activity profiles of oversimplified peptides lacking in the protonable N-terminus.

  2012cited by this paper
• Crystal structure of the μ-opioid receptor bound to a morphinan antagonist

  2012cited by this paper
• Expedient synthesis of pseudo-Pro-containing peptides: towards constrained peptidomimetics and foldamers.

  2012cited by this paper
• Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs

  2012cited by this paper
• Molecular docking of opiates and opioid peptides, a tool for the design of selective agonists and antagonists, and for the investigation of atypical ligand-receptor interactions.

  2012cited by this paper
• The Inverse Type II β‐Turn on D‐Trp‐Phe, a Pharmacophoric Motif for MOR Agonists

  2011cited by this paper
• Unexpected Opioid Activity Profiles of Analogues of the Novel Peptide Kappa Opioid Receptor Ligand CJ‐15,208

  2011cited by this paper
• Total synthesis of (-)-indolactam V.

  2011cited by this paper
• Kinetic studies of novel inhibitors of endomorphin degrading enzymes

  2011cited by this paper
• Tripeptide motifs in biology: targets for peptidomimetic design.

  2011cited by this paper
• Peripherally acting opioids and clinical implications for pain control.

  2011cited by this paper
• Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A

  2011cited by this paper
• Ag-Catalyzed diastereo- and enantioselective synthesis of beta-substituted tryptophans from sulfonylindoles.

  2010cited by this paper
• CoMFA analyses of C-2 position salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity.

  2010cited by this paper
• Recent Advances in Endomorphin Engineering

  2010cited by this paper
• Synthesis and biological evaluation of cyclic endomorphin-2 analogs

  2010cited by this paper
• Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.

  2010cited by this paper
• Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization.

  2010cited by this paper
• A simple route towards peptide analogues containing substituted (S)- or (R)-tryptophans

  2010cited by this paper
• Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues.

  2010cited by this paper
• "Carba"-analogues of fentanyl are opioid receptor agonists.

  2010cited by this paper
• Use of the SPhos ligand to suppress racemization in arylpinacolboronate ester Suzuki couplings involving alpha-amino acids. Synthesis of biaryl derivatives of 4-hydroxyphenylglycine, tyrosine, and tryptophan.

  2009cited by this paper
• Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208.

  2009cited by this paper
• Cyclic Opioid Peptide Agonists and Antagonists Obtained Via Ring‐Closing Metathesis

  2009cited by this paper
• Total synthesis of (-)-ardeemin.

  2009cited by this paper
• Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor.

  2009cited by this paper
• Investigation of the interaction between the atypical agonist c[YpwFG] and MOR

  2008cited by this paper
• Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.

  2008cited by this paper
• New endomorphin analogues containing alicyclic beta-amino acids: influence on bioactive conformation and pharmacological profile.

  2008cited by this paper
• The facile synthesis of a series of tryptophan derivatives

  2008cited by this paper
• Endomorphin-2 with a beta-turn backbone constraint retains the potent micro-opioid receptor agonist properties.

  2008cited by this paper
• Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor.

  2008cited by this paper
• Endomorphin-2 with a β-turn backbone constraint retains the potent μ-opioid receptor agonist properties

  2008cited by this paper
• Re-discussion of the importance of ionic interactions in stabilizing ligand-opioid receptor complex and in activating signal transduction.

  2007cited by this paper
• Concise, asymmetric, stereocontrolled total synthesis of stephacidins A, B and notoamide B.

  2007cited by this paper
• The five bromotryptophans

  2007cited by this paper
• The influence of drug-like concepts on decision-making in medicinal chemistry

  2007cited by this paper
• Topological exploration of cyclic endomorphin-1 analogues, structurally defined models for investigating the bioactive conformation of MOR agonists.

  2007cited by this paper
• A convenient enzymatic synthesis of L-halotryptophans.

  2006cited by this paper
• Peptides and peptidomimetics in medicine, surgery and biotechnology.

  2006cited by this paper
• Probing protein folding and conformational transitions with fluorescence.

  2006cited by this paper
• Robust in vitro activity of RebF and RebH, a two-component reductase/halogenase, generating 7-chlorotryptophan during rebeccamycin biosynthesis.

  2005cited by this paper
• Synthesis and biological activity of N-methylated analogs of endomorphin-2.

  2005cited by this paper
• Biochemical properties of peptides encrypted in bovine milk proteins.

  2005cited by this paper
• Recent advances in selective opioid receptor agonists and antagonists

  2004cited by this paper
• Recent advances in the investigation of the bioactive conformation of peptides active at the micro-opioid receptor. conformational analysis of endomorphins.

  2004cited by this paper
• Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.

  2004cited by this paper
• Synthesis of optically active ring-A substituted tryptophans as IDO inhibitors

  2004cited by this paper
• Synthesis and evaluation of the affinity toward mu-opioid receptors of atypical, lipophilic ligands based on the sequence c[-Tyr-Pro-Trp-Phe-Gly-].

  2004cited by this paper
• New trends in the development of opioid peptide analogues as advanced remedies for pain relief.

  2004cited by this paper
• Conformational analysis and mu-opioid receptor affinity of short peptides, endomorphin models in a low polarity solvent.

  2003cited by this paper
• Stability against enzymatic hydrolysis of endomorphin-1 analogues containing beta-proline.

  2003cited by this paper
• A novel N-terminal cyclic dynorphin A analogue cyclo(N,5)[Trp(3),Trp(4),Glu(5)] dynorphin A-(1-11)NH(2) that lacks the basic N-terminus.

  2003cited by this paper
• Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline.

  2003cited by this paper
• CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502.

  2002cited by this paper
• Development and validation of opioid ligand-receptor interaction models: the structural basis of mu vs delta selectivity.

  2002cited by this paper
• Endomorphin-1 Analogues Containing β-Proline Are μ-Opioid Receptor Agonists and Display Enhanced Enzymatic Hydrolysis Resistance

  2002cited by this paper
• Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

  2002cited by this paper
• Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

  2002cited by this paper
• Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance.

  2002cited by this paper
• Design, synthesis, and evaluation of opioid analogues with non-peptidic beta-turn scaffold: enkephalin and endomorphin mimetics.

  2002cited by this paper
• Convenient synthesis of 7′ and 6′-bromo-d-tryptophan and their derivatives by enzymatic optical resolution using d-aminoacylase

  2002cited by this paper
• Efficient asymmetric synthesis of biologically important tryptophan analogues via a palladium-mediated heteroannulation reaction.

  2001cited by this paper
• Synthesis and binding activity of endomorphin-1 analogues containing β-amino acids

  2000cited by this paper
• Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.

  2000cited by this paper
• Novel ligands lacking a positive charge for the δ- and μ-opioid receptors

  2000cited by this paper
• Synthesis and binding activity of endomorphin-1 analogues containing beta-amino acids.

  2000cited by this paper
• Pharmacology of amphibian opiate peptides.

  2000cited by this paper
• Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.

  1999cited by this paper
• A potent and selective endogenous agonist for the µ-opiate receptor

  1997cited by this paper

• Computational Pharmacodynamic Analysis of Cyclopeptides Derived from c[Trp-Phe-D-Pro-Phe] (CJ-15,208), an Unusual Class of Mixed μ/k-Opioid Receptor Ligands Lacking the Traditional Pharmacophores

  2026cites this paper
• Applications of biaryl cyclization in the synthesis of cyclic enkephalin analogs with a highly restricted flexibility

  2024cites this paper
• Identification of c[D-Trp-Phe-β-Ala-β-Ala], the First κ-Opioid Receptor-Specific Negative Allosteric Modulator.

  2024cites this paper
• Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects

  2023cites this paper
• Synthesis and Antiproliferative Activity against Cancer Cells of Indole-Aryl-Amide Derivatives

  2022cites this paper
• Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation

  2020cites this paper
• Green synthesis of bioactive oligopeptides promoted by recyclable nanocrystalline hydroxyapatite.

  2020cites this paper
• Development of Novel δ Opioid Receptor Inverse Agonists without a Basic Nitrogen Atom and Their Antitussive Effects in Mice.

  2019cites this paper